| scholarly article | Q13442814 |
| P50 | author | Kazuaki Chayama | Q87781872 |
| Takaaki Sugihara | Q88792181 | ||
| Kinya Okamoto | Q89919273 | ||
| Hideyuki Hyogo | Q92613257 | ||
| Akira Hiramatsu | Q114882283 | ||
| P2093 | author name string | Shuichi Sato | |
| Hajime Isomoto | |||
| Yoshikazu Murawaki | |||
| Jun Kato | |||
| Keisuke Hino | |||
| Yuichi Hara | |||
| Miwa Kawanaka | |||
| Takumi Onoyama | |||
| Masahiko Koda | |||
| Toshiaki Okamoto | |||
| Hiroshi Tobita | |||
| Manabu Kishina | |||
| Shiho Tokunaga | |||
| Tomomitsu Matono | |||
| Kenichi Miyoshi | |||
| P2860 | cites work | Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis | Q24201595 |
| Fructose consumption as a risk factor for non-alcoholic fatty liver disease | Q24657933 | ||
| Fructose as a key player in the development of fatty liver disease | Q27014596 | ||
| The combined hyperlipidemia caused by impaired Wnt-LRP6 signaling is reversed by Wnt3a rescue | Q27022615 | ||
| Identification of novel genes coding for small expressed RNAs | Q27860917 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases | Q28131780 | ||
| Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists | Q28131785 | ||
| Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells | Q28245307 | ||
| Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease | Q28275665 | ||
| Human RISC couples microRNA biogenesis and posttranscriptional gene silencing | Q28280424 | ||
| Regulation of fatty acid and cholesterol metabolism by the AMP-activated protein kinase | Q28282199 | ||
| Phosphorylation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase and modulation of its enzymic activity by calcium-activated and phospholipid-dependent protein kinase | Q28291633 | ||
| Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice | Q28507402 | ||
| Exosomes: composition, biogenesis and function | Q29547721 | ||
| Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease | Q29614897 | ||
| Characterization of microRNA expression profiles in normal human tissues | Q29615492 | ||
| The natural history of nonalcoholic fatty liver disease: a population-based cohort study | Q29617161 | ||
| Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis | Q29619888 | ||
| Endpoints and clinical trial design for nonalcoholic steatohepatitis | Q33583798 | ||
| Acid sphingomyelinase deficiency in Western diet-fed mice protects against adipocyte hypertrophy and diet-induced liver steatosis | Q33600495 | ||
| Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives | Q33702810 | ||
| Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions | Q33731663 | ||
| Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease | Q33780172 | ||
| NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk. | Q33844463 | ||
| Expression of p53, Bax and Bcl-2 proteins in hepatocytes in non-alcoholic fatty liver disease | Q33869030 | ||
| MicroRNAs in liver disease | Q33880442 | ||
| Triglyceride is strongly associated with nonalcoholic fatty liver disease among markers of hyperlipidemia and diabetes | Q33932461 | ||
| Circulating insulin-like growth factor-1 and its binding protein-3: metabolic and genetic correlates in the community | Q33936965 | ||
| Liver alkaline phosphatase: a missing link between choleresis and biliary inflammation | Q34043010 | ||
| MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer. | Q53160000 | ||
| GH-independent IGF-I action is essential to prevent the development of nonalcoholic steatohepatitis in a GH-deficient rat model. | Q53165282 | ||
| A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells. | Q53213170 | ||
| Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. | Q53416418 | ||
| Statin use and non-alcoholic steatohepatitis in at risk individuals. | Q53504568 | ||
| Deletion of Smad4 attenuates the hepatic inflammation and fibrogenesis during nonalcoholic steatohepatitis progression. | Q54091023 | ||
| Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4-dependent. | Q54334813 | ||
| Is there a higher incidence of maternal uniparental disomy 14 [upd(14)mat]? Detection of 10 new patients by methylation-specific PCR. | Q54587662 | ||
| Increased Hepatic PDGF-AA Signaling Mediates Liver Insulin Resistance in Obesity Associated Type 2 Diabetes. | Q54979728 | ||
| Prediction of functional microRNA targets by integrative modeling of microRNA binding and target expression data | Q61445398 | ||
| Genetic Liver-Specific AMPK Activation Protects against Diet-Induced Obesity and NAFLD | Q61451626 | ||
| The role of the microbiome in NAFLD and NASH | Q61812480 | ||
| The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD | Q61989968 | ||
| Alkaline phosphatase | Q69162289 | ||
| Bile acid-dependent secretion of alkaline phosphatase in rat bile | Q70401470 | ||
| IL-6 and IGF-1 are independent prognostic factors of liver steatosis and non-alcoholic steatohepatitis in morbidly obese patients | Q80561407 | ||
| Prolonged saturated fat-induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysregulated enteroadipocyte axis as a novel feature of fatty liver | Q83182075 | ||
| Toxic lipids stored by Kupffer cells correlates with their pro-inflammatory phenotype at an early stage of steatohepatitis | Q83679148 | ||
| Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline | Q84164931 | ||
| Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity | Q85195754 | ||
| The differential effects of high-fat and high- -fructose diets on the liver of male albino rat and the proposed underlying mechanisms | Q90226054 | ||
| MicroRNA-379 suppresses cell proliferation, migration and invasion in nasopharyngeal carcinoma by targeting tumor protein D52 | Q90991008 | ||
| Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease. | Q50786458 | ||
| Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis. | Q50959265 | ||
| Alkaline phosphatase: can it be considered as an indicator of liver fibrosis in non-alcoholic steatohepatitis with type 2 diabetes? | Q51374753 | ||
| Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. | Q51535040 | ||
| Insulin-Like Growth Factor (IGF) System in Liver Diseases. | Q52558393 | ||
| CREB and FoxO1: two transcription factors for the regulation of hepatic gluconeogenesis | Q34049345 | ||
| Differential expression of microRNAs in adipose tissue after long-term high-fat diet-induced obesity in mice | Q34230389 | ||
| Noninvasive biomarkers for the diagnosis of steatohepatitis and advanced fibrosis in NAFLD. | Q34256132 | ||
| Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease | Q34427653 | ||
| CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis | Q34432561 | ||
| Involvement of AMP-activated protein kinase in beneficial effects of betaine on high-sucrose diet-induced hepatic steatosis | Q34433803 | ||
| The metabolic syndrome as a predictor of nonalcoholic fatty liver disease | Q34467576 | ||
| Statins: mechanism of action and effects. | Q34687736 | ||
| Serum alkaline phosphatase levels in healthy children and evaluation of alkaline phosphatase z-scores in different types of rickets | Q34727638 | ||
| Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. | Q34779049 | ||
| microRNA-379 couples glucocorticoid hormones to dysfunctional lipid homeostasis | Q35116623 | ||
| Oxidative stress promotes pathologic polyploidization in nonalcoholic fatty liver disease | Q35183888 | ||
| Inflammatory stress increases hepatic CD36 translational efficiency via activation of the mTOR signalling pathway | Q35210594 | ||
| Exosome and exosomal microRNA: trafficking, sorting, and function | Q35543884 | ||
| Combined Serum Biomarkers in Non-Invasive Diagnosis of Non-Alcoholic Steatohepatitis | Q35676997 | ||
| Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease | Q35893923 | ||
| Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease | Q35965687 | ||
| The Upregulation of Genomic Imprinted DLK1-Dio3 miRNAs in Murine Lupus Is Associated with Global DNA Hypomethylation | Q35986953 | ||
| Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease | Q35993416 | ||
| A Series of microRNA in the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse Model | Q36005098 | ||
| TGF-β-SMAD3 signaling mediates hepatic bile acid and phospholipid metabolism following lithocholic acid-induced liver injury | Q36387273 | ||
| Nonalcoholic fatty liver disease presenting with an isolated elevated alkaline phosphatase | Q36569279 | ||
| Endothelial function and vascular oxidative stress in long-lived GH/IGF-deficient Ames dwarf mice | Q37038972 | ||
| The P72R Polymorphism of p53 Predisposes to Obesity and Metabolic Dysfunction | Q37051221 | ||
| Genomic imprinting at the mammalian Dlk1-Dio3 domain | Q37159981 | ||
| Concentrations of connective tissue growth factor in patients with nonalcoholic fatty liver disease: association with liver fibrosis. | Q37262078 | ||
| Role of growth hormone, insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 in development of non-alcoholic fatty liver disease | Q37278051 | ||
| Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression | Q37280624 | ||
| IGF-I induces senescence of hepatic stellate cells and limits fibrosis in a p53-dependent manner | Q37323927 | ||
| Patients with Nonalcoholic Fatty Liver Disease (NAFLD) have Higher Oxidative Stress in Comparison to Chronic Viral Hepatitis | Q37613985 | ||
| FOXO transcription factors protect against the diet-induced fatty liver disease | Q37704641 | ||
| Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease | Q38072666 | ||
| Roles for PI3K/AKT/PTEN Pathway in Cell Signaling of Nonalcoholic Fatty Liver Disease | Q38083661 | ||
| Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis | Q38090905 | ||
| Epigenetic analysis of the Dlk1-Gtl2 imprinted domain on mouse chromosome 12: implications for imprinting control from comparison with Igf2-H19. | Q38293388 | ||
| Early to Phase II drugs currently under investigation for the treatment of liver fibrosis | Q38303313 | ||
| Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis | Q38310080 | ||
| Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH. | Q38356462 | ||
| Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. | Q38680300 | ||
| MicroRNA-379-5p plays a tumor-suppressive role in human bladder cancer growth and metastasis by directly targeting MDM2. | Q38703700 | ||
| MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma | Q38788862 | ||
| Role of thrombospondin 1 in liver diseases. | Q38918913 | ||
| Bioinformatic identification of IGF1 as a hub gene in hepatocellular carcinoma (HCC) and in-vitro analysis of the chemosensitizing effect of miR-379 via suppressing the IGF1/IGF1R signaling pathway | Q39041421 | ||
| Fructose and NAFLD: The Multifaceted Aspects of Fructose Metabolism | Q39168770 | ||
| Nonalcoholic fatty liver disease is associated with low circulating levels of insulin-like growth factor-I. | Q39494990 | ||
| Regulation of acetyl-CoA carboxylase | Q40090698 | ||
| PEGylated Curcumin Derivative Attenuates Hepatic Steatosis via CREB/PPAR-γ/CD36 Pathway | Q40097108 | ||
| HGF ameliorates a high-fat diet-induced fatty liver | Q40152004 | ||
| Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells | Q40313352 | ||
| Fish Oil Feeding Modulates the Expression of Hepatic MicroRNAs in a Western-Style Diet-Induced Nonalcoholic Fatty Liver Disease Rat Model. | Q41038410 | ||
| MicroRNA-206 prevents hepatosteatosis and hyperglycemia by facilitating insulin signaling and impairing lipogenesis | Q41495543 | ||
| MicroRNA-379 inhibits the proliferation, migration and invasion of human osteosarcoma cells by targetting EIF4G2 | Q41881466 | ||
| miR-379 Inhibits Cell Proliferation, Invasion, and Migration of Vascular Smooth Muscle Cells by Targeting Insulin-Like Factor-1. | Q42147279 | ||
| Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up | Q42201783 | ||
| Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention | Q45067817 | ||
| Interleukin-10 is a protective factor against diet-induced insulin resistance in liver | Q46759227 | ||
| MicroRNA-379 suppresses cervical cancer cell proliferation and invasion by directly targeting V-crk avian sarcoma virus CT10 oncogene homolog-like | Q47558801 | ||
| Nonalcoholic fatty liver disease impairs expression of the type II inositol 1,4,5-trisphosphate receptor | Q47662853 | ||
| Current and future pharmacological therapies for NAFLD/NASH. | Q47778507 | ||
| Pathogenesis of non-alcoholic fatty liver disease mediated by YAP. | Q50057357 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P921 | main subject | metabolic dysfunction–associated steatotic liver disease | Q1546498 |
| non-alcoholic fatty liver | Q66299798 | ||
| P304 | page(s) | e0219412 | |
| P577 | publication date | 2020-02-27 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Serum miR-379 expression is related to the development and progression of hypercholesterolemia in non-alcoholic fatty liver disease | |
| P478 | volume | 15 |
Search more.